Clinical Guidelines
Newsletter of the European Monitoring Centre for Drugs and Drug Addiction
In this issue: New technical report on estimating trends in injecting drug use |EMCDDA: 20 years of monitoring | Memorandum of Understanding with Armenia |EMCDDA launches IPA 5 project with the Western Balkans | New EMCDDA products and services | Selection procedure for new EMCDDA Director.
In this issue: New technical report on estimating trends in injecting drug use |EMCDDA: 20 years of monitoring | Memorandum of Understanding with Armenia |EMCDDA launches IPA 5 project with the Western Balkans | New EMCDDA products and services | Selection procedure for new EMCDDA Director.
Russia's war on drugs leaves patients without pain relief
A change to the Russian law governing narcotics now enshrines a terminally ill patient's right to pain relief, but that doesn't necessarily mean they can get the drugs they need.
A change to the Russian law governing narcotics now enshrines a terminally ill patient's right to pain relief, but that doesn't necessarily mean they can get the drugs they need.
Alternatives to punishment for drug-using offenders
Based on the options provided by the international drug control legal framework, this paper considers the rehabilitative measures of treating, educating or reintegrating drug users as alternatives or additions to conviction or punishment that are established in the laws of many countries in Europe today.
Based on the options provided by the international drug control legal framework, this paper considers the rehabilitative measures of treating, educating or reintegrating drug users as alternatives or additions to conviction or punishment that are established in the laws of many countries in Europe today.
Improving access to, and completion of, hepatitis C treatment
This briefing provides an overview of the key issues that local providers and commissioners of drug and hepatitis treatment should consider.
This briefing provides an overview of the key issues that local providers and commissioners of drug and hepatitis treatment should consider.
Injecting risk practices and Hepatitis C
The primary objectives of this study were to determine the extent of injecting risk behaviours among a typical sample of people who inject drugs (PWID), and to compare the drug use and risk behaviours of PWID who reported anti-HCV positive and negative results.
The primary objectives of this study were to determine the extent of injecting risk behaviours among a typical sample of people who inject drugs (PWID), and to compare the drug use and risk behaviours of PWID who reported anti-HCV positive and negative results.
Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study
BMJ - Associations between benzodiazepine prescribing patterns including dose, type, and dosing schedule and the risk of death from drug overdose among US veterans receiving opioid analgesics.
BMJ - Associations between benzodiazepine prescribing patterns including dose, type, and dosing schedule and the risk of death from drug overdose among US veterans receiving opioid analgesics.
Predicting recidivism for offenders in UK substance dependence treatment: do mental health symptoms matter?
The purpose of this paper is to assess whether mental health symptoms affect one-year reoffending rates upon release from prison for participants engaging in substance dependence treatment in the UK.
The purpose of this paper is to assess whether mental health symptoms affect one-year reoffending rates upon release from prison for participants engaging in substance dependence treatment in the UK.
World Drug Report 2015
The World Drug Report presents a comprehensive annual overview of the latest developments in the world's illicit drug markets by focusing on the production, trafficking and consumption of the main types of illicit drugs, along with the related health consequences of those drugs.
The World Drug Report presents a comprehensive annual overview of the latest developments in the world's illicit drug markets by focusing on the production, trafficking and consumption of the main types of illicit drugs, along with the related health consequences of those drugs.
New psychoactive substances in Europe: Innovative legal responses
This short report provides an overview of how European countries are developing innovative legal responses to the challenges presented to public health and drug policy by the rapidly evolving market for new psychoactive substances.
This short report provides an overview of how European countries are developing innovative legal responses to the challenges presented to public health and drug policy by the rapidly evolving market for new psychoactive substances.
SMMGP Clinical Update June 2015
Highlights include: Fatal poisoning by methadone or buprenorphine in England and Wales. Injection into the femoral vein among people who inject drugs in urban areas of England. Women's injection drug practices in their own words: a qualitative study. Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail Designer drugs 2015: assessment and management.
Highlights include: Fatal poisoning by methadone or buprenorphine in England and Wales. Injection into the femoral vein among people who inject drugs in urban areas of England. Women's injection drug practices in their own words: a qualitative study. Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail Designer drugs 2015: assessment and management.
